Demystifying Medicine Video



In recent months, the relationship between the medication Hydroxychloroquine and the treatment or prevention of Covid-19 has generated a lot of buzz. This video highlights recent research evidence regarding the use of Hydroxychloroquine for Covid-19. We also discuss the traditional uses of Hydroxychloroquine, and the potential side-effects that have been associated with this medication.
This video was created for educational and entertainment purposes only, and is not a substitute for professional medical advice. If you have questions about any medical condition or treatment, always seek the advice of your physician or other qualified healthcare provider.

[Please complete our feedback form]





References
  • Angelakis, E., et. al. (2014). Abnormal weight gain and gut microbiota modifications are side effects of long-term doxycycline and hydroxychloroquine treatment. Antimicrobial agents and chemotherapy, 58(6), 3342-3347
  • Boulware, D. R., et. al. (2020). A randomized trial of hydroxychloroquine as postexposure prophylaxis for Covid-19. New England Journal of Medicine. 
  • Celı̇k, I., Onay-Besı̇kcı̇, A., & Ayhan-Kilcigı̇l, G. (2020). Approach to the mechanism of action of hydroxychloroquine on SARS-CoV-2: a molecular docking study. Journal of Biomolecular Structure and Dynamics, 1-7.  
  • Chatre, C., Roubille, F., Vernhet, H., Jorgensen, C., & Pers, Y. M. (2018). Cardiac complications attributed to chloroquine and hydroxychloroquine: a systematic review of the literature. Drug safety, 41(10), 919-931.
  • ClinicalTrials.gov. Bethesda (MD): National Library of Medicine (US). Search of: Hydroxychloroquine: Covid19 - List Results. (2020 October 24). Retrieved
  • Cohen, M. S. (2020). Hydroxychloroquine for the Prevention of Covid-19—Searching for Evidence.  
  • Coronavirus (COVID-19) Update: FDA Revokes Emergency Use Authorization for Chloroquine and Hydroxychloroquine.
  • Fantini, J., Di Scala, C., Chahinian, H., & Yahi, N. (2020). Structural and molecular modeling studies  reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection. International journal of antimicrobial agents, 105960.  
  • Gao, J., Tian, Z., & Yang, X. (2020). Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Bioscience Trends, 14(1), 72–73. https:// doi.org/10.5582/bst.2020.01047 
  • Gevers, S., Kwa, M. S. G., Wijnans, E., & van Nieuwkoop, C. (2020). Safety considerations for chloroquine and hydroxychloroquine in the treatment of COVID-19. Clinical Microbiology and Infection, 26(9), 1276-1277.
  • Hernandez, A. V., Roman, Y. M., Pasupuleti, V., Barboza, J. J., & White, C. M. (2020). Hydroxychloroquine or chloroquine for treatment or prophylaxis of COVID-19: a living systematic review. Annals of Internal Medicine. 
  • Liu, J., Cao, R., Xu, M., Wang, X., Zhang, H., Hu, H., Li, Y., Hu, Z., Zhong, W., Wang, M. (2020). Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 Infection in vitro. Cell Discovery, 6(1), 1–4. 
  • Martins, A. C., Cayotopa, A. D. E., Klein, W. W., Schlosser, A. R., Silva, A. F. D., Souza, M. N. D., ... & da Silva-Nunes, M. (2015). Side effects of chloroquine and primaquine and symptom reduction in malaria endemic area (Mâncio Lima, Acre, Brazil). Interdisciplinary perspectives on infectious diseases, 2015.
  • Naghipour, S., Ghodousi, M., Rahsepar, S., & Elyasi, S. (2020). Repurposing of well- known   medications as antivirals: hydroxychloroquine and chloroquine–from HIV-1 infection to COVID-19. Expert Review of Anti-infective Therapy, 1-15.  
  • Ochsendorf, F. R., & Runne, U. (1991). Chloroquine and hydroxychloroquine: side effect profile of important therapeutic drugs. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 42(3), 140-146.
  • Sharma, A. N., Mesinkovska, N. A., & Paravar, T. (2020). Characterizing the adverse dermatologic effects of hydroxychloroquine: a systematic review. Journal of the American Academy of Dermatology.
  • Srinivasa, A., tosounidou, S., & gordon, C. (2017). Increased incidence of gastrointestinal side effects in patients taking hydroxychloroquine: a brand-related issue?. The Journal of rheumatology, 44(3), 398-398.
  • Wallace, D. (1996). The history of antimalarials. Lupus, 5, 2-3. doi:10.1177/0961203396005001021
  • Yusuf, I. H., Sharma, S., Luqmani, R., & Downes, S. M. (2017). Hydroxychloroquine retinopathy. Eye, 31(6), 828-845.
  • Zhou, D., Dai, S.-M., & Tong, Q. (2020). COVID-19: a recommendation to examine the effect of hydroxychloroquine in preventing infection and progression. Journal of Antimicrobial Chemotherapy, 75(7), 1667–1670